Orion Biotechnology Presented at the 3rd GPCR-Targeted Drug Discovery Summit in Boston

13.03.2024

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...

Orion Biotechnology featured on BestStock.com

29.08.2023

You can find the investment blog – BestStocks.com – and their take on the potential of Orion’s technology in a recently published article here.

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months

18.07.2023

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...

Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston

18.02.2023

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled...